JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chu, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chu, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 39, Issue of September 26, 1997 pp. 24097-24100
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

MINIREVIEW:
Double Strand Break Repair*

Gilbert Chu Dagger

From the Departments of Medicine and Biochemistry, Stanford University School of Medicine, Stanford, California 94305

INTRODUCTION
Mutant Cell Lines
Ku and DNA-dependent Protein Kinase
Genes for Double Strand Break Repair
DNA End Joining in Intact Cells
DNA End Joining versus Homologous Recombination
DNA End Joining in Cell-free Extracts
Model for the End-joining Reaction
Other Roles for DNA End-joining Proteins
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


INTRODUCTION

<UP>       This was the most unkindest cut of all …</UP>
<UP>       Then I, and you, and all of us fell down,</UP>
<UP>       Whilst bloody treason flourished over us </UP>(<UP>1</UP>)<UP>.</UP>
DNA double strand breaks (DSBs)1 may be the most disruptive form of DNA damage. If left unrepaired, they lead to broken chromosomes and cell death. If repaired improperly, they can lead to chromosome translocations and cancer. Humans are at risk for DSBs from exogenous agents. The paradigm agent, ionizing radiation, is present in the environment mainly from the decay of radon gas, which accumulates in homes to different levels depending on the uranium content of the underlying soil. Ionizing radiation is also utilized in medicine for diagnostic x-rays and for treating cancer patients. Anticancer drugs will generate DSBs as well: bleomycin produces oxidative free radicals, which induce strand breaks; etoposide and adriamycin inhibit topoisomerase II to create protein-bridged DSBs. Humans are also at risk for DSBs from endogenous agents. Oxidative metabolism generates free radicals and subsequent strand breaks. V(D)J recombination generates DSBs during rearrangement of genes encoding B cell immunoglobulins and T cell receptors (2).

In response to the threat of DSBs, cells have evolved at least two independent pathways for repairing DSBs, by homologous recombination or by nonhomologous DNA end joining. This review will focus on recent progress in understanding the dominant mechanism in mammalian cells, nonhomologous end joining.


Mutant Cell Lines

Immunological diversity is generated by V(D)J recombination (Fig. 1), a site-specific cleavage of the chromosome followed by an end-joining reaction to bring the free DNA ends together (2). The possibility that DSB repair and V(D)J recombination might share the same biochemical pathway was first recognized in the severe combined immunodeficiency (scid) mouse. The scid mouse lacks mature B and T cells due to a defect in V(D)J recombination (3) and is also hypersensitive to ionizing radiation due to a defect in DSB repair (4-6). Screening of other x-ray-sensitive cell lines (Table I) led to the identification of three genetic complementation groups with defects in both DSB repair and V(D)J recombination (7, 8). Since efforts were under way to complement these rodent cell lines with human genes, the genes for the complementation groups were designated XRCC, for x-ray cross-complementing. XRCC7 mutant cells (scid mouse cells and V3 hamster cells) were severely defective in coding joint formation but only mildly defective in signal joint formation. By contrast, XRCC4 and XRCC5 mutant cells were severely defective in both coding and signal joint formation.


Fig. 1. DNA intermediates in V(D)J recombination. Recombination signal sequences (triangles) consist of a conserved heptamer adjacent to a coding segment followed by a 12- or 23-bp spacer and a conserved nonamer. Signal sequences are recognized pairwise according to the "12/23" rule, in which one signal sequence must contain a 12-bp spacer and the other a 23-bp spacer. This pairwise recognition is presumably mediated by the synapsis of the two signal sequences. The recombination activating gene products, RAG1 and RAG2, then cleave DNA adjacent to recombination signal sequences to produce hairpin coding ends and blunt signal ends (72). The coding ends are joined to form a modified coding joint, and the signal ends are finally joined to form a precise signal joint.
[View Larger Version of this Image (21K GIF file)]

Table I. Genetics of double strand break repair

Genetic complementation groups, corresponding to the x-ray cross-complementing genes, XRCC4-XRCC7, have been assigned for cell lines hypersensitive to ionizing radiation and defective in V(D)J recombination. The XRCC6 mutant cell line was generated by targeted knockout of mouse embryonic stem cells. a.a., amino acid.

Mutated gene V(D)J defect Mutant cells Mutation

XRCC4 Coding/signal XR-1 Gene deletion (39)
XRCC5 (Ku86) Coding/signal XR-V9B Internal a.a. deletion (30)
XR-V15B Internal a.a. deletion (30)
xrs4 Truncated 287-a.a. protein (31)
xrs5 ?
xrs6 Truncated 24-a.a. protein (31)
sxi1 ?
sxi2 ?
sxi3 ?
XRCC6 (Ku70) Coding/signal ES cells Knockout (73)
XRCC7 (DNA-PKcs) Coding scid Terminal 83-a.a. truncation (37, 38)
V3 ?


Ku and DNA-dependent Protein Kinase

The path toward isolating the XRCC5 and XRCC7 genes began with identification of the Ku protein as an autoantigen in scleroderma-polymyositis overlap syndrome (9, 10). In the hope of gaining insight into the pathogenesis of autoimmune disease, Ku was extensively characterized.

Ku is a heterodimer of 70 and 86 kDa (Ku70 and Ku86) that binds with strong affinity to DNA ends, stem-loop or bubble structures, or transitions between double-stranded DNA and two single strands (11, 12). Once Ku binds to DNA, it can translocate along the DNA, so that three or more Ku molecules can bind to a single linear DNA fragment (13, 14). If the linear DNA is then ligated into a circle, Ku can no longer dissociate, consistent with a model in which Ku molecules bind to DNA like beads on a string. Ku is a DNA-dependent ATPase that is activated by both double- and single-stranded DNA (15). Both Ku70 and Ku86 contain motifs for potential ATP binding sites. Ku has also been reported to have an ATP-dependent 3' to 5' helicase activity (16).

Ku is the regulatory subunit for DNA-dependent protein kinase (DNA-PK), which has the unusual property of remaining quiescent until activated by DNA ends (17). DNA-PK contains an enormous catalytic subunit of 465 kDa (DNA-PKcs) that is activated when Ku binds to DNA. DNA-PK will phosphorylate serine or threonine residues that immediately precede glutamine in a large number of protein substrates in vitro (18). Interestingly, DNA-PK will phosphorylate Ku in vitro, activating its ATPase activity (15). However, attempts to identify in vivo substrates have been inconclusive. For example, DNA-PK will phosphorylate p53 in vitro but is not required for the accumulation or activation of p53 (19, 20).


Genes for Double Strand Break Repair

A DNA end binding (DEB) factor was detected by an electrophoretic mobility shift assay (21). This assay was used to screen a large number of x-ray-sensitive cell lines, and DEB factor was absent in three different cell lines, all belonging to the complementation group for XRCC5 (21). DEB factor proved to be both biochemically and antigenically similar to Ku (22, 23). Furthermore, the XRCC5 and Ku86 genes were independently mapped to the same human chromosome locus, 2q33-35 (24-26).

To demonstrate that Ku86 and XRCC5 are identical, an expression vector for Ku86 was transfected into the mutant XRCC5 hamster cells. Transfection of human Ku86 rescued the mutant hamster cells for DEB activity, DNA-PK enzymatic activity, x-ray resistance, and V(D)J recombination (27, 28). Transfection of Ku86 also restored resistance to the topoisomerase II inhibitor etoposide (29). Thus Ku is involved in the repair of DNA DSBs produced by ionizing radiation, V(D)J recombination, or etoposide.

XRCC5 cells were found to contain mutations in the Ku86 gene (30, 31), leading to functionally significant alterations in Ku86 (Table I). As expected, the generation of Ku86 knockout mice produced severe immunodeficiency due to an absence of both T and B cells (32, 33). Both coding and signal joint formation were impaired, and the coding joint defect was accompanied by accumulation of hairpin coding ends in Ku86 knockout thymocytes. Unexpectedly, the Ku86 knockout mice also displayed marked growth retardation (32), suggesting that Ku might have an additional unforseen role.

The discovery that Ku86 was defective in XRCC5 mutant cells raised the possibility that DNA-PKcs might be defective in XRCC7 cells (34-36). Indeed, DNA-PK enzymatic activity and DNA-PKcs protein levels were severely reduced in both scid and V3 cells. When genomic yACs containing the DNA-PKcs gene were transfected into scid and V3 cells, DNA-PK enzymatic activity, ionizing radiation resistance, and coding joint formation were restored. Furthermore, the DNA-PKcs gene was mutated in scid cells, producing a premature termination codon in the putative kinase domain that truncates the C-terminal 83 amino acids (37, 38).

As in Ku86 knockout thymocytes, scid thymocytes accumulate hairpin coding ends (33). Therefore, Ku and DNA-PK are required for the proper processing of hairpin ends. Ku or DNA-PK do not have an endonuclease activity that opens the hairpin ends directly. Instead, DNA-PK enzymatic activity may make the hairpin accessible to a still unidentified hairpin endonuclease.

The only known XRCC4 cell line, XR-1, is rescued by transfection of a cDNA encoding a 37-kDa protein, restoring both ionizing radiation resistance and V(D)J recombination to wild-type levels (39). XRCC4 is a novel gene, lacking homology to other known genes. It is deleted in XR-1 cells and therefore not essential for growth. The sensitivity of XR-1 cells increases dramatically in the G1 phase of the cell cycle (40), and any proposed role for XRCC4 must account for this phenomenon.


DNA End Joining in Intact Cells

End joining of naked DNA has been studied by introducing linear DNA into intact cells. When linearized plasmid DNA was injected into Xenopus oocytes, a low level of plasmid recircularization occurred (41). The end-joining reaction resulted in junctions containing deletions back to regions of microhomology of 1-10 bases within 20 bp of the ends. When linearized SV40 DNA was transfected into mammalian cells, end joining either occurred by direct joining of the ends or by the deletions back to regions of microhomology of 1-6 bases (42, 43). Direct joining occurred even for ends with protruding ends of opposite polarity (5' protruding and 3' protruding). The joining events utilizing microhomology were proposed to be directed by base pairing of the microhomology regions (Fig. 2), thus aligning the DNA ends for subsequent steps in the end-joining reaction. Interestingly, end joining also occurred occasionally with the insertion of nucleotides from a number of sources, including free oligonucleotides in the nucleus, copying errors near the DSB by slipped mispairing and repair synthesis, and misincorporation of A residues during repair of a 5' single-stranded extension (44).


Fig. 2. Microhomology alignment during end joining. The repair of DNA double strand breaks may result in deletions from the DNA ends. In the majority of cases, the deletions extend back to regions of microhomology of 1-6 nucleotides. Shown is a joining event after cleavage with StuI in the APRT chromosomal locus (45). Upon cleavage, the DNA ends might be aligned by base pairing in the region of microhomology.
[View Larger Version of this Image (23K GIF file)]

To study end joining of chromosomal DNA, restriction enzymes have been used to introduce DSBs at specific chromosomal sites. Restriction enzymes were electroporated into Chinese hamster ovary cells, which are hemizygous at the APRT (adenine phosphoribosyltransferase) locus (45). Colonies of viable cells containing mutations in APRT were then analyzed at the DNA sequence level. Mutations consisted of insertions, small deletions up to 36 bp, and combinations of insertions and deletions at the cleavage sites. Most of the deletions involved the utilization of microhomology of 1-4 bases at the recombination junctions. Because this method scored for induced mutations in APRT, the full spectrum of end-joining events could not be observed. Nevertheless, the end-joining reactions observed with transfected naked DNA and chromosomal DNA shared key characteristics: nucleotide insertions and nucleotide deletions directed by microhomology.

Rare cutting restriction enzymes have been used to introduce a single or very few DSBs into the mammalian genome (46). Chinese hamster ovary cells were engineered to contain a single I-SceI site disrupting an integrated neo gene. Repair of the induced DSB reconstructed an intact neo gene if the end joining occurred with deletion of the ends back to a region of 4-base microhomology. In this system, XRCC5 mutant cells were severely defective in rejoining the DSB by at least 3 orders of magnitude compared with wild-type hamster cells.

V(D)J recombination junctions provide additional insight into end joining of broken chromosomes (2). Coding joint formation occurs with both insertion and deletion of nucleotides. Many insertions occur by mechanisms specific for lymphoid cells. Palindromic (P-nucleotide) insertions are generated by the asymmetric cleavage of the hairpin coding ends. Nontemplated (N-nucleotide) insertions are catalyzed by lymphoid-specific terminal deoxynucleotidyltransferase (TdT). However, nucleotide insertion will still occur in TdT knockout mice (47). Nucleotide deletion is also best studied in TdT knockout mice, since TdT-catalyzed insertions can obscure the nature of the deletions. In the absence of TdT, 75% of the joining events contain deletions directed by microhomology regions of 1-5 nucleotides (47, 48). Thus, the joining reaction for coding ends during V(D)J recombination confirms the characteristics observed for random DSBs in nonlymphoid cells. The proposed DNA intermediates for the end-joining reaction are shown in Fig. 3.


Fig. 3. DNA intermediates in nonhomologous end joining. V(D)J recombination and nonhomologous end joining share similarities in the nature of the DNA intermediates and the participating proteins. Thus, it is likely that the end joining reaction proceeds by a series of steps reminiscent of V(D)J recombination: synapsis of the DNA ends and alignment by microhomology pairing. Microhomology alignment could occur by unwinding of the DNA ends (as shown). Alternatively, it could occur by strand invasion and displacement or by exonuclease digestion of one of the strands on each end. Gap filling and ligation then complete the repair of the double strand break.
[View Larger Version of this Image (15K GIF file)]

In contrast to coding joint formation, signal joint formation is precise and depends on Ku but not on an intact kinase domain in DNA-PKcs. Thus, the mechanisms that lead to the insertion and deletion of nucleotides are somehow suppressed during the formation of signal ends.


DNA End Joining versus Homologous Recombination

Cells are capable of repairing DSBs either by homologous recombination or by nonhomologous end joining. Genetic screens suggest that the relative importance of these two mechanisms is quite different in yeast and mammalian cells. In Saccharomyces cerevisiae, screens for mutants sensitive to ionizing radiation have produced many mutant alleles of genes involved in homologous recombination (49), but not genes involved in nonhomologous end joining. Furthermore, yeast knocked out for the genes homologous to mammalian Ku have normal sensitivity to ionizing radiation (50-53). Nevertheless, yeast Ku is involved in DSB repair. Yeast Ku70 mutants fail to recircularize linearized plasmids (50, 52). They also fail to survive when induced to express EcoRI, which causes DSBs at the same position in both sister chromatids, precluding repair by homologous recombination (51). Furthermore, when homologous recombination is eliminated in a rad52 mutant, disruption of yeast Ku70 confers additional radiation hypersensitivity (53). Thus, S. cerevisiae repairs DSBs preferentially by homologous recombination, while using Ku-dependent end joining as a secondary pathway when homologous recombination is not possible.

By contrast, mutant screens in mammalian cells for sensitivity to ionizing radiation have yielded mutant alleles for Ku and DNA-PKcs but not alleles for genes involved in homologous recombination. When cells are engineered with DNA chromosomal substrates that permit the repair of DSBs by either homologous recombination or by nonhomologous end joining, the great majority of the joining events occurs by nonhomologous end joining (54-57). Thus, in contrast to yeast, mammalian cells repair DSBs preferentially by nonhomologous end joining.


DNA End Joining in Cell-free Extracts

Progress toward defining nonhomologous end joining in a cell-free system has been relatively slow. End joining was studied in Xenopus extracts by recircularization of linear DNA molecules with different types of DNA ends (58, 59). In contrast to results in intact mammalian cells, nucleotide deletion was not observed beyond losses from protruding single strands. Short regions of microhomology were utilized but only if the homologous base pairs were available within the protruding single-stranded regions of the same polarity. Interestingly, substrates with opposite polarities (5' protruding and 3' protruding ends) were joined by the alignment of single strands, gap filling, and ligation. Such an unusual activity was found for Klenow fragment of DNA polymerase I from Escherichia coli (60), suggesting that a vertebrate polymerase might accomplish the same thing.

End joining in mammalian extracts has been studied by the recircularization of pUC18 plasmid DNA cleaved with different restriction enzymes. Almost all events involved direct joining of the cohesive ends, but there were a small number of misrejoined molecules with insertions or deletions utilizing regions of microhomology. By making DSBs with noncohesive ends, it was possible to fractionate extracts into four different end-joining activities (61). The activity that utilized microhomology near the ends could be purified extensively (62). However, none of the activities was dependent on the presence of Ku protein, suggesting that this cell-free system had detected a secondary end-joining mechanism.

There is reason for optimism that Ku-dependent end joining can be studied in cell-free systems for the special case of signal joint formation (63). When a substrate containing V(D)J recombination signal sequences was incubated with purified RAG1 and RAG2 and HeLa extracts, the substrate was cleaved and the signal ends were joined with appropriate precision. Furthermore, signal joining could be blocked by anti-Ku antibodies. This result, while promising, must be verified with extracts from Ku-deficient cells.


Model for the End-joining Reaction

The properties of Ku and DNA-PK can be used to formulate a model for how these proteins might facilitate DNA end joining (Fig. 4). When the chromosome is broken, Ku protects the DNA ends from degradation until end joining is completed. In support of this, when Ku86 mutant cells were tested for V(D)J recombination, the few signal joining events that were recovered contained large deletions (8). Similarly, when Ku mutant cells were transfected with linearized plasmid DNA, they exhibited excess degradation of the DNA ends (64). Finally, purified Ku protein protected free DNA ends from exonuclease degradation in vitro (23).


Fig. 4. Model for the role of Ku and DNA-PKcs in nonhomologous end joining. The DNA double strand break is recognized by Ku (shaded heterodimer). DNA-PKcs (diagonally hatched subunit) is then recruited to the site and assembled into an active DNA-PK complex. The DNA-PK complex contains one binding site for DNA ends and a second binding site for double-stranded DNA internal to the ends, thus mediating the synapsis of the opposing DNA ends. Once synapsis is achieved, DNA-PK can trans-phosphorylate Ku and DNA-PKcs bound to the opposing end. This leads to the dissociation of DNA-PKcs and the activation of Ku helicase, which unwinds the DNA to allow microhomology base pairing. The unpaired DNA flaps are resolved, and the DNA is ligated to complete the repair process.
[View Larger Version of this Image (25K GIF file)]

On binding to the DNA ends, Ku recruits DNA-PKcs. Synapsis of the two DNA ends might be mediated by two independent DNA binding sites on DNA-PK or by the association of two DNA-PK molecules.

DNA-PK phosphorylates both DNA-PKcs and Ku subunits in vitro (65). We hypothesize that this phosphorylation occurs in trans, so that the kinase assembled on one DNA end phosphorylates the DNA-PK subunits assembled on the other DNA end. Activity in trans would regulate the kinase activity so that processing of the DNA ends would occur only after synapsis of the two ends is accomplished.

Upon phosphorylation by DNA-PK in vitro, DNA-PKcs dissociates from Ku (65), and Ku acquires helicase activity (15, 16). We postulate that this helicase activity unwinds DNA ends in vivo so that exposed regions of microhomology can anneal by base pairing. The unpaired DNA flaps could then be removed either by an exonuclease or a flap endonuclease. A flap endonuclease, FEN-1, has the appropriate enzymatic activity (66), although its role in DSB repair and V(D)J recombination has not been established. Gaps are then filled in by a DNA polymerase and the nicks sealed by ligase to complete the end-joining process.

The hypothesis that DNA-PK phosphorylates in trans has implications for V(D)J recombination. Recall that the joining of signal ends occurs precisely and does not require intact kinase activity. When a pair of signal and coding ends is created by RAG1/RAG2 cleavage, DNA-PK would assemble on the signal end and phosphorylate Ku bound to the opposing coding end, activating the Ku helicase. The hairpin end would then be processed to allow cleavage by a presumed hairpin endonuclease. The reverse reaction is quite different: DNA-PK assembled on the hairpin end remains inactive as a kinase in vitro. Thus, Ku bound to the signal end would remain unphosphorylated, preventing processing of the signal ends. Therefore, the transphosphorylation hypothesis explains why the joining of signal ends is precise and why it is unaffected by the scid mutation.

To test this model, experiments are needed to determine the effect of abrogating Ku helicase activity. Of note, mutation of the conserved ATP binding site in Ku86 has no effect (31), but a similar experiment has not been performed for the ATP binding site in Ku70. Experiments must also determine whether the helicase activity of Ku will unwind DNA ends and whether Ku is an in vivo substrate for DNA-PK. A knockout of the entire DNA-PKcs gene is needed to determine whether the enormous catalytic subunit has additional biochemical activities. To complete the model, many questions must be answered. What is the role of the XRCC4 protein in the end-joining reaction? What protein has hairpin endonuclease activity? What proteins are required for alignment of the ends by microhomology base pairing? What proteins process the unpaired DNA flaps after alignment?


Other Roles for DNA End-joining Proteins

The pathway for nonhomologous DNA end joining has evolved for other roles beyond its primary role in joining broken chromosomes. It has been hypothesized that RAG1 and RAG2 were originally introduced into the mammalian genome by an ancient retroviral infection (67). V(D)J recombination could then have evolved by combining the cleavage activity of RAG1/RAG2 with the pre-existing Ku-dependent end-joining activity for broken chromosomes. Such a dual use of end joining is also seen in Drosophila melanogaster, which utilizes Ku for both P-element transposition and DNA repair (68).

Mammalian cells may have additional roles for Ku. Ku86 knockout mice display marked growth retardation (32), suggesting a role for Ku other than in DNA repair or V(D)J recombination. Such roles include involvement in transcription by RNA polymerase I (69, 70) or RNA polymerase II (12, 71). Data from yeast suggest roles in regulating replication and in maintaining telomere length (51).

In conclusion, the study of how cells repair double strand breaks has revealed a primordial end-joining mechanism. Further study promises to illuminate not just the repair of broken chromosomes but other critical pathways in DNA metabolism.


FOOTNOTES

*   This minireview will be reprinted in the 1997 Minireview Compendium, which will be available in December, 1997. This is the second article of four in the "Eukaryotic DNA Repair Minireview Series." This research was supported by Grant DAMD 17-94-J-4350 from the United States Army Medical Research and Materiel Command.
Dagger    To whom correspondence should be addressed: M211, Dept. of Medicine (Oncology), Stanford University Medical Center, Stanford, CA 94305-5306. Tel.: 415-725-6442; Fax: 415-725-1420; E-mail: chu{at}cmgm.stanford.edu.
1   The abbreviations used are: DSB, double strand break; DEB, DNA end binding; DNA-PK, DNA-dependent protein kinase; DNA-PKcs, catalytic subunit of DNA-dependent protein kinase; RAG1 and RAG2, recombination activating genes 1 and 2; TdT, terminal deoxynucleotidyltransferase; XRCC, x-ray cross-complementing; bp, base pair(s).
2   V. Smider, K. Rathmell, G. Brown, S. Lewis, and G. Chu, unpublished data.

ACKNOWLEDGEMENTS

I thank Kim Rathmell, Vaughn Smider, and Ola Hammarsten for helpful discussions and critical reading of the manuscript.


REFERENCES

  1. Shakespeare, W. (1598) Julius Caesar, Act III, scene ii
  2. Smider, V., and Chu, G. (1997) Semin. Immunol. 9, 189-197 [CrossRef][Medline] [Order article via Infotrieve]
  3. Lieber, M. R., Hesse, J. E., Lewis, S., Bosma, G. C., Rosenberg, N., Mizuuchi, K., Bosma, M. J., and Gellert, M. (1988) Cell 55, 7-16 [CrossRef][Medline] [Order article via Infotrieve]
  4. Biedermann, K., Sun, J., Giaccia, A., Tosto, L., and Brown, J. M. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 1394-1397 [Abstract/Free Full Text]
  5. Fulop, G., and Phillips, R. (1990) Nature 347, 479-482 [CrossRef][Medline] [Order article via Infotrieve]
  6. Hendrickson, E., Qin, X. Q., Bump, E., Schatz, D., Oettinger, M., and Weaver, D. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 4061-4065 [Abstract/Free Full Text]
  7. Pergola, F., Zdzienicka, M. Z., and Lieber, M. R. (1993) Mol. Cell. Biol. 13, 3464-3471 [Abstract/Free Full Text]
  8. Taccioli, G., Rathbun, G., Oltz, E., Stamato, T., Jeggo, P., and Alt, F. (1993) Science 260, 207-210 [Abstract/Free Full Text]
  9. Mimori, T., Akizuki, M., Yamagata, H., Inada, S., Yoshida, S., and Homma, M. (1981) J. Clin. Invest. 68, 611-620
  10. Reeves, W. (1992) Rheum. Dis. Clin. North Am. 18, 391-415 [Medline] [Order article via Infotrieve]
  11. Mimori, T., and Hardin, J. A. (1986) J. Biol. Chem. 261, 10375-10379 [Abstract/Free Full Text]
  12. Falzon, M., Fewell, J. W., and Kuff, E. L. (1993) J. Biol. Chem. 268, 10546-10552 [Abstract/Free Full Text]
  13. de Vries, E., van Driel, W., Bergsma, W. G., Arnberg, A. C., and van der Vliet, P. C. (1989) J. Mol. Biol. 208, 65-78 [CrossRef][Medline] [Order article via Infotrieve]
  14. Paillard, S., and Strauss, F. (1991) Nucleic Acids Res. 19, 5619-5624 [Abstract/Free Full Text]
  15. Cao, Q., Pitt, S., Leszyk, J., and Baril, E. (1994) Biochemistry 33, 8548-8557 [CrossRef][Medline] [Order article via Infotrieve]
  16. Tuteja, N., Tuteja, R., Ochem, A., Taneja, P., Huang, N., Simoncsits, A., Susic, S., Rahman, K., Marusic, L., Chen, J., Zhang, J., Wang, S., Pongor, S., and Falaschi, A. (1994) EMBO J. 13, 4991-5001 [Medline] [Order article via Infotrieve]
  17. Gottlieb, T., and Jackson, S. (1993) Cell 72, 131-142 [CrossRef][Medline] [Order article via Infotrieve]
  18. Anderson, C. (1993) Trends Biochem. Sci. 18, 433-437 [CrossRef][Medline] [Order article via Infotrieve]
  19. Fried, L. M., Koumenis, C., Peterson, S. R., Green, S. L., van Zijl, P., Allalunis-Turner, J., Chen, D. C., Fishel, R., Giaccia, A. J., Brown, J. M., and Kirchgessner, C. U. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 13825-13830 [Abstract/Free Full Text]
  20. Rathmell, W. K., Kaufmann, W. K., Hurt, J. C., Byrd, L. L., and Chu, G. (1997) Cancer Res. 57, 68-74 [Abstract/Free Full Text]
  21. Rathmell, W. K., and Chu, G. (1994) Mol. Cell. Biol. 14, 4741-4748 [Abstract/Free Full Text]
  22. Rathmell, W. K., and Chu, G. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 7623-7627 [Abstract/Free Full Text]
  23. Getts, R., and Stamato, T. (1994) J. Biol. Chem. 269, 15981-15984 [Abstract/Free Full Text]
  24. Chen, D. J., Marrone, B. L., Nguyen, T., Stackhouse, M., Zhao, Y., and Siciliano, M. J. (1994) Genomics 21, 423-427 [CrossRef][Medline] [Order article via Infotrieve]
  25. Hafezparast, M., Kaur, G., Zdzienicka, M., Athwal, R., Lehmann, A., and Jeggo, P. (1993) Somatic Cell Mol. Genet. 19, 413-421 [CrossRef][Medline] [Order article via Infotrieve]
  26. Cai, Q.-Q., Plet, A., Imbert, J., Lafage-Pochitaloff, M., Cerdan, C., and Blanchard, J.-M. (1994) Cytogenet. Cell Genet. 65, 221-227 [Medline] [Order article via Infotrieve]
  27. Taccioli, G., Gottlieb, T., Blunt, T., Priestly, A., Demengeot, J., Mizuta, R., Lehmann, A., Alt, F., Jackson, S., and Jeggo, P. (1994) Science 265, 1442-1445 [Abstract/Free Full Text]
  28. Smider, V., Rathmell, W. K., Lieber, M., and Chu, G. (1994) Science 266, 288-291 [Abstract/Free Full Text]
  29. He, D. M., Lee, S. E., and Hendrickson, E. A. (1996) Mutat. Res. 363, 43-56 [CrossRef][Medline] [Order article via Infotrieve]
  30. Errami, A., Smider, V., Rathmell, W. K., He, D., Hendrickson, E. A., Zdzienicka, M., and Chu, G. (1996) Mol. Cell. Biol. 16, 1519-1526 [Abstract]
  31. Singleton, B., Priestly, A., Steingrimsdottir, H., Gell, D., Blunt, T., Jackson, S., Lehmann, A., and Jeggo, P. (1997) Mol. Cell. Biol. 17, 1264-1273 [Abstract]
  32. Nussenzweig, A., Chen, C., da Costa Soares, V., Sanchez, M., Nussenzweig, M., and Li, G. (1996) Nature 382, 551-555 [CrossRef][Medline] [Order article via Infotrieve]
  33. Zhu, C., Bogue, M., Lim, D. S., Hasty, P., and Roth, D. (1996) Cell 86, 379-389 [CrossRef][Medline] [Order article via Infotrieve]
  34. Blunt, T., Finnie, N., Taccioli, G., Smith, G., Demengeot, J., Gottlieb, T., Mizuta, R., Varghese, A., Alt, F., Jeggo, P., and Jackson, S. (1995) Cell 80, 813-823 [CrossRef][Medline] [Order article via Infotrieve]
  35. Kirchgessner, C., Patil, C., Evans, J., Cuomo, C., Fried, L., Carter, T., Oettinger, M., and Brown, J. M. (1995) Science 267, 1178-1185 [Abstract/Free Full Text]
  36. Peterson, S., Kurimasa, A., Oshimura, M., Dynan, W., Bradbury, E., and Chen, D. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 3171-3174 [Abstract/Free Full Text]
  37. Blunt, T., Gell, D., Fox, M., Taccioli, G., Jackson, S., Lehman, A., and Jeggo, P. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 10285-10290 [Abstract/Free Full Text]
  38. Danska, J., Holland, D., Mariathasan, S., Williams, K., and Guidos, C. (1996) Mol. Cell. Biol. 10, 6472-6481
  39. Li, Z., Otevrel, T., Gao, Y., Cheng, H.-L., Seed, B., Stamato, T. D., Taccioli, G. E., and Alt, F. W. (1995) Cell 83, 1079-1089 [CrossRef][Medline] [Order article via Infotrieve]
  40. Giaccia, A., Weinstein, R., Hu, J., and Stamato, T. D. (1985) Somatic Cell Mol. Genet. 11, 485-491 [CrossRef][Medline] [Order article via Infotrieve]
  41. Grzesiuk, E., and Carroll, D. (1987) Nucleic Acids Res. 15, 971-985 [Abstract/Free Full Text]
  42. Roth, D. B., Porter, T. N., and Wilson, J. H. (1985) Mol. Cell. Biol. 5, 2599-2607 [Abstract/Free Full Text]
  43. Roth, D. B., and Wilson, J. H. (1986) Mol. Cell. Biol. 6, 4295-4304 [Abstract/Free Full Text]
  44. Roth, D. B., Chang, X., and Wilson, J. H. (1989) Mol. Cell. Biol. 9, 3049-3057 [Abstract/Free Full Text]
  45. Phillips, J., and Morgan, W. (1994) Mol. Cell. Biol. 14, 5794-5803 [Abstract/Free Full Text]
  46. Liang, F., Romanienko, P., Weaver, D., Jeggo, P., and Jasin, M. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 8929-8933 [Abstract/Free Full Text]
  47. Gilfillan, S., Dierich, A., Lemeur, M., Benoist, C., and Mathis, D. (1993) Science 261, 1175-1178 [Abstract/Free Full Text]
  48. Komori, T., Okada, A., Stewart, V., and Alt, F. (1993) Science 261, 1171-1175 [Abstract/Free Full Text]
  49. Friedberg, E. C., Walker, G. C., and Siede, W. (1995) DNA Repair and Mutagenesis, pp. 555-567, American Society for Microbiology, Washington, D. C.
  50. Boulton, S., and Jackson, S. (1996) Nucleic Acids Res. 24, 4639-4648 [Abstract/Free Full Text]
  51. Barnes, G., and Rio, D. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 867-872 [Abstract/Free Full Text]
  52. Milne, G. T., Jin, S., Shannon, K. B., and Weaver, D. T. (1996) Mol. Cell. Biol. 16, 4189-4198 [Abstract]
  53. Siede, W., Friedl, A., Dianova, I., Eckardt-Schupp, F., and Friedberg, E. (1996) Genetics 142, 91-102 [Abstract]
  54. Godwin, A., Bollag, R., Christie, D., and Liskay, M. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 12554-12558 [Abstract/Free Full Text]
  55. Jeong-yu, S., and Carroll, D. (1992) Mol. Cell. Biol. 12, 112-119 [Abstract/Free Full Text]
  56. Lukacsovich, T., Yang, D., and Waldman, A. (1994) Nucleic Acids Res. 22, 5649-5657 [Abstract/Free Full Text]
  57. Sargent, R., Brenneman, M., and Wilson, J. (1997) Mol. Cell. Biol. 17, 267-277 [Abstract]
  58. Thode, S., Schafer, A., Pfeiffer, P., and Vielmetter, W. (1990) Cell 60, 921-928 [CrossRef][Medline] [Order article via Infotrieve]
  59. Pfeiffer, P., Thode, S., Hancke, J., and Vielmetter, W. (1994) Mol. Cell. Biol. 14, 888-895 [Abstract/Free Full Text]
  60. King, J., Fairly, C., and Morgan, W. (1996) J. Biol. Chem. 271, 20450-20457 [Abstract/Free Full Text]
  61. Johnson, A., and Fairman, M. (1996) Mutat. Res. 364, 103-116 [CrossRef][Medline] [Order article via Infotrieve]
  62. Mason, R., Thacker, J., and Fairman, M. (1996) Nucleic Acids Res. 24, 4946-4953 [Abstract/Free Full Text]
  63. Cortes, P., Weis-Garcia, F., Misulovin, Z., Nussenzweig, A., Lai, J.-S., Li, G., Nussenzweig, M. C., and Baltimore, D. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 14008-14013 [Abstract/Free Full Text]
  64. Liang, F., and Jasin, M. (1996) J. Biol. Chem. 271, 14405-14411 [Abstract/Free Full Text]
  65. Chan, D., and Lees-Miller, S. (1996) J. Biol. Chem 271, 8936-8941 [Abstract/Free Full Text]
  66. Harrington, J. J., and Lieber, M. R. (1995) J. Biol. Chem. 270, 4503-4508 [Abstract/Free Full Text]
  67. Thompson, C. B. (1995) Immunity 5, 531-539
  68. Beall, E., and Rio, D. (1996) Genes Dev. 10, 921-933 [Abstract/Free Full Text]
  69. Hoff, C., Ghosh, A., Prabhakar, B., and Jacob, S. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 762-766 [Abstract/Free Full Text]
  70. Kuhn, A., Gottlieb, T., Jackson, S., and Grummt, I. (1995) Genes Dev. 9, 193-203 [Abstract/Free Full Text]
  71. Giffin, W., Torrance, H., Rodda, D., Prefontaine, G., Pope, L., and Hache, R. (1996) Nature 380, 265-268 [CrossRef][Medline] [Order article via Infotrieve]
  72. McBlane, F., van Gent, D., Ramsden, D., Romeo, C., Cuomo, C., Gellert, M., and Oettinger, M. (1995) Cell 83, 387-395 [CrossRef][Medline] [Order article via Infotrieve]
  73. Gu, Y., Jin, S., Gao, Y., Weaver, D., and Alt, F. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 8076-8081 [Abstract/Free Full Text]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. R. Lieber
The Mechanism of Human Nonhomologous DNA End Joining
J. Biol. Chem., January 4, 2008; 283(1): 1 - 5.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
S. MARTIEN and C. ABBADIE
Acquisition of Oxidative DNA Damage during Senescence: The First Step toward Carcinogenesis?
Ann. N.Y. Acad. Sci., November 1, 2007; 1119(1): 51 - 63.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
N. Windbichler, P. A. Papathanos, F. Catteruccia, H. Ranson, A. Burt, and A. Crisanti
Homing endonuclease mediated gene targeting in Anopheles gambiae cells and embryos
Nucleic Acids Res., September 27, 2007; 35(17): 5922 - 5933.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
L. Shi, D. Qiu, G. Zhao, B. Corthesy, S. Lees-Miller, W. H. Reeves, and P. N. Kao
Dynamic binding of Ku80, Ku70 and NF90 to the IL-2 promoter in vivo in activated T-cells
Nucleic Acids Res., April 1, 2007; 35(7): 2302 - 2310.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I.-Y. Chang, C.-K. Youn, H.-B. Kim, M.-H. Kim, H.-J. Cho, Y. Yoon, Y.-S. Lee, M.-H. Chung, and H. J. You
Oncogenic H-Ras Up-regulates Expression of Ku80 to Protect Cells from {gamma}-Ray Irradiation in NIH3T3 Cells
Cancer Res., August 1, 2005; 65(15): 6811 - 6819.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
J. A. Smith, B. C. Waldman, and A. S. Waldman
A Role for DNA Mismatch Repair Protein Msh2 in Error-Prone Double-Strand-Break Repair in Mammalian Chromosomes
Genetics, May 1, 2005; 170(1): 355 - 363.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
R. D. Kennedy, J. E. Quinn, P. B. Mullan, P. G. Johnston, and D. P. Harkin
The Role of BRCA1 in the Cellular Response to Chemotherapy
J Natl Cancer Inst, November 17, 2004; 96(22): 1659 - 1668.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Adachi, S. So, and H. Koyama
Loss of Nonhomologous End Joining Confers Camptothecin Resistance in DT40 Cells: IMPLICATIONS FOR THE REPAIR OF TOPOISOMERASE I-MEDIATED DNA DAMAGE
J. Biol. Chem., September 3, 2004; 279(36): 37343 - 37348.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
S. E. Liberti and L. J. Rasmussen
Is hEXO1 a Cancer Predisposing Gene?
Mol. Cancer Res., August 1, 2004; 2(8): 427 - 432.
[Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Kampmann and D. Stock
Reverse gyrase has heat-protective DNA chaperone activity independent of supercoiling
Nucleic Acids Res., July 6, 2004; 32(12): 3537 - 3545.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Yang, Y. Yu, H. E. Hamrick, and P. J. Duerksen-Hughes
ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses
Carcinogenesis, October 1, 2003; 24(10): 1571 - 1580.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Adachi, H. Suzuki, S. Iiizumi, and H. Koyama
Hypersensitivity of Nonhomologous DNA End-joining Mutants to VP-16 and ICRF-193: IMPLICATIONS FOR THE REPAIR OF TOPOISOMERASE II-MEDIATED DNA DAMAGE
J. Biol. Chem., September 19, 2003; 278(38): 35897 - 35902.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
N.G. Oliveira, M. Castro, A.S. Rodrigues, I.C. Goncalves, O.M. Gil, A.P. Fernandes, J.M. Toscano-Rico, and J. Rueff
Wortmannin enhances the induction of micronuclei by low and high LET radiation
Mutagenesis, January 1, 2003; 18(1): 37 - 44.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Sak, M. Stuschke, R. Wurm, G. Schroeder, B. Sinn, G. Wolf, and V. Budach
Selective Inactivation of DNA-dependent Protein Kinase with Antisense Oligodeoxynucleotides: Consequences for the Rejoining of Radiation-induced DNA Double-Strand Breaks and Radiosensitivity of Human Cancer Cell Lines
Cancer Res., November 15, 2002; 62(22): 6621 - 6624.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. C. Stern, D. M. Umbach, R. M. Lunn, and J. A. Taylor
DNA Repair Gene XRCC3 Codon 241 Polymorphism, Its Interaction with Smoking and XRCC1 Polymorphisms, and Bladder Cancer Risk
Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 939 - 943.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Zhong, C.-F. Chen, P.-L. Chen, and W.-H. Lee
BRCA1 Facilitates Microhomology-mediated End Joining of DNA Double Strand Breaks
J. Biol. Chem., August 2, 2002; 277(32): 28641 - 28647.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Mori, S. M. Colman, Z. Xiao, A. M. Ford, L. E. Healy, C. Donaldson, J. M. Hows, C. Navarrete, and M. Greaves
Chromosome translocations and covert leukemic clones are generated during normal fetal development
PNAS, June 11, 2002; 99(12): 8242 - 8247.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.